Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Britten

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Nature Communications|December 18, 2025
Dysfunctional CD4 T cells in an oncovirus-specific TCR-transgenic in vivo modelFelicia S Spitzer, Marcel G M Camps, Cedrik M Britten, et al.
Cancer Immunology, Immunotherapy : CII|June 16, 2010
Response definition criteria for ELISPOT assays revisitedZ Moodie, L Price, C Gouttefangeas, et al.
Cancer Immunology Research|September 24, 2014
Functional TCR retrieval from single antigen-specific human T cells reveals multiple novel epitopesPetra Simon, Tana A Omokoko, Andrea Breitkreuz, et al.
Immunity|October 17, 2009
"MIATA"-minimal information about T cell assaysSylvia Janetzki, Cedrik M Britten, Michael Kalos, et al.
Plos Computational Biology|July 23, 2013
Hierarchical modeling for rare event detection and cell subset alignment across flow cytometry samplesAndrew Cron, Cécile Gouttefangeas, Jacob Frelinger, et al.
Cancer Informatics|June 19, 2015
Managing Multi-center Flow Cytometry Data for Immune MonitoringScott White, Karoline Laske, Marij Jp Welters, et al.
Cancer Immunology, Immunotherapy : CII|January 6, 2016
Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim studySusanna Mandruzzato, Sven Brandau, Cedrik M Britten, et al.
Cancer Immunology, Immunotherapy : CII|November 10, 2012
Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocolsHelene Filbert, Sebastian Attig, Nicole Bidmon, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2014
Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junctionMarie-Cristine Kuehnle, Sebastian Attig, Cedrik M Britten, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2004
Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumorsValérie Vantomme, Christine Dantinne, Noreddine Amrani, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Nature Communications|December 18, 2025
Dysfunctional CD4 T cells in an oncovirus-specific TCR-transgenic in vivo modelFelicia S Spitzer, Marcel G M Camps, Cedrik M Britten, et al.
Cancer Immunology, Immunotherapy : CII|June 16, 2010
Response definition criteria for ELISPOT assays revisitedZ Moodie, L Price, C Gouttefangeas, et al.
Cancer Immunology Research|September 24, 2014
Functional TCR retrieval from single antigen-specific human T cells reveals multiple novel epitopesPetra Simon, Tana A Omokoko, Andrea Breitkreuz, et al.
Immunity|October 17, 2009
"MIATA"-minimal information about T cell assaysSylvia Janetzki, Cedrik M Britten, Michael Kalos, et al.
Plos Computational Biology|July 23, 2013
Hierarchical modeling for rare event detection and cell subset alignment across flow cytometry samplesAndrew Cron, Cécile Gouttefangeas, Jacob Frelinger, et al.
Cancer Informatics|June 19, 2015
Managing Multi-center Flow Cytometry Data for Immune MonitoringScott White, Karoline Laske, Marij Jp Welters, et al.
Cancer Immunology, Immunotherapy : CII|January 6, 2016
Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim studySusanna Mandruzzato, Sven Brandau, Cedrik M Britten, et al.
Cancer Immunology, Immunotherapy : CII|November 10, 2012
Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocolsHelene Filbert, Sebastian Attig, Nicole Bidmon, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2014
Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junctionMarie-Cristine Kuehnle, Sebastian Attig, Cedrik M Britten, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2004
Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumorsValérie Vantomme, Christine Dantinne, Noreddine Amrani, et al.
Pageof 11